Dear Partners and Customers,
At SQUARE Pharmaceuticals, our vision has always been to ensure access to world-class medicines while upholding the highest standards of quality, ethics, and sustainability. With the establishment of SQUARE Pharmaceuticals Kenya EPZ Ltd, we have taken a significant step toward serving the people of Kenya and Africa more closely.
Our investment in Kenya is not only a commitment to the region’s healthcare development but also a reflection of our confidence in its potential as a hub for innovation and growth. Guided by international quality benchmarks and a strong ethical foundation, SQUARE has earned the trust of healthcare professionals and patients in more than 40 countries.
Looking ahead, we are planning to expand our Kenyan facility with new Liquid and Sterile manufacturing units in coming days, ensuring a broader portfolio of essential medicines produced locally.
This investment underscores our long-term vision of building a sustainable healthcare ecosystem that supports local employment, knowledge transfer, and improved access to affordable, reliable treatment.
Together with our partners, we aim to shape a healthier future for Kenya and Africa.
Sincerely,
Tapan Chowdhury
Managing Director
SQUARE